PULSE the living trend engine
🤖 Open Intelligence Dossier available for AI agents & citation View Markdown (.md) →
▲ Peaking Health

Patients running out of options as antibiotics stop working against common infections

European health agencies warn that drug-resistant infections are surging in hospitals while antibiotics lose effectiveness against common bacteria.

6sources
6articles
4velocity
+31%since first seen
2h agofirst detected

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

The brief

Coverage from NL Times, CIDRAP, the European Policy Centre, the European Centre for Disease Prevention and Control, POLITICO.eu and UN News on 18 November 2026 describes a worsening antimicrobial resistance situation across Europe. NL Times reports that more bacteria in the Netherlands are becoming resistant to antibiotics. The European Centre for Disease Prevention and Control highlights carbapenem-resistant Enterobacterales as a growing threat. POLITICO.eu states that deadly drug-resistant infections are surging in European hospitals. UN News warns that patients are running out of options as antibiotics stop working against common infections. CIDRAP notes that European officials are calling for swift and sustained action on antimicrobial resistance. The European Policy Centre argues that the EU is missing the mark on One Health targets.

The coverage emphasizes coordinated alarm from multiple European health and policy institutions on the same day. NL Times provides a national-level observation from the Netherlands. The European Centre for Disease Prevention and Control issues a specific pathogen-focused alert on carbapenem-resistant Enterobacterales. POLITICO.eu frames the issue as a hospital crisis with deadly infections surging. UN News presents the human impact of treatment options disappearing. CIDRAP relays the official call for urgent policy response. The European Policy Centre critiques the EU's progress on One Health targets, which integrate human, animal and environmental health approaches.

The context linking these reports is the One Health framework that the European Policy Centre says the EU is failing to meet. Carbapenem-resistant Enterobacterales are a family of bacteria that have developed resistance to carbapenem antibiotics, often considered last-resort treatments. The convergence of national surveillance data from the Netherlands, EU-wide pathogen monitoring from the European Centre for Disease Prevention and Control, hospital-level reporting from POLITICO.eu, and policy analysis from the European Policy Centre suggests the problem spans surveillance, clinical care and governance levels simultaneously.

What to watch next includes whether European officials translate their call for swift and sustained action into concrete policy measures, whether the EU revises its One Health strategy to address the gaps identified by the European Policy Centre, whether carbapenem-resistant Enterobacterales surveillance data shows continued spread across more member states, and whether hospitals report further increases in untreatable infections. Coverage does not yet specify new funding commitments, regulatory changes or clinical guideline updates.

Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 46m ago.

Quick answers

Which specific bacteria are highlighted as a growing threat?

The European Centre for Disease Prevention and Control highlights carbapenem-resistant Enterobacterales as a growing threat.

What policy framework is the EU said to be missing targets on?

The European Policy Centre argues that the EU is missing the mark on One Health targets.

What action are European officials calling for?

CIDRAP reports that European officials call for swift and sustained action on antimicrobial resistance.

Coverage (6)

Topics

Related trends

\n \n \n \n \n \n \n